[go: up one dir, main page]

NO20014783D0 - DNA-sekvens som koder for interleukin-1-inhibitorer og fremgangsmåte til fremstilling av forbindelsene - Google Patents

DNA-sekvens som koder for interleukin-1-inhibitorer og fremgangsmåte til fremstilling av forbindelsene

Info

Publication number
NO20014783D0
NO20014783D0 NO20014783A NO20014783A NO20014783D0 NO 20014783 D0 NO20014783 D0 NO 20014783D0 NO 20014783 A NO20014783 A NO 20014783A NO 20014783 A NO20014783 A NO 20014783A NO 20014783 D0 NO20014783 D0 NO 20014783D0
Authority
NO
Norway
Prior art keywords
inhibitors
preparing
compounds
sequence encoding
dna sequence
Prior art date
Application number
NO20014783A
Other languages
English (en)
Other versions
NO20014783L (no
NO316917B1 (no
Inventor
Charles H Hannon
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20014783L publication Critical patent/NO20014783L/no
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO20014783D0 publication Critical patent/NO20014783D0/no
Publication of NO316917B1 publication Critical patent/NO316917B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20014783A 1988-05-27 2001-10-01 Fremgangsmate til fremstilling av et farmasoytisk preparat inneholdende en interleukin-1-inhibitor NO316917B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US23871388A 1988-08-31 1988-08-31
US26653188A 1988-11-03 1988-11-03
PCT/US1989/002275 WO1989011540A1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Publications (3)

Publication Number Publication Date
NO20014783L NO20014783L (no) 1991-01-28
NO20014783D0 true NO20014783D0 (no) 2001-10-01
NO316917B1 NO316917B1 (no) 2004-06-21

Family

ID=27394086

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19905090A NO316122B1 (no) 1988-05-27 1990-11-23 DNA-sekvens som koder for interleukin-1-inhibitorer, rekombinant vektor sominneholder og kan kode DNA-sekvensen, vertcelle som inneholder ogkan uttrykkevektorer, og fremgangsmåte til fremstilling av interleukin-1-inhibitorer, og rekombinant vertcelle s
NO20014783A NO316917B1 (no) 1988-05-27 2001-10-01 Fremgangsmate til fremstilling av et farmasoytisk preparat inneholdende en interleukin-1-inhibitor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19905090A NO316122B1 (no) 1988-05-27 1990-11-23 DNA-sekvens som koder for interleukin-1-inhibitorer, rekombinant vektor sominneholder og kan kode DNA-sekvensen, vertcelle som inneholder ogkan uttrykkevektorer, og fremgangsmåte til fremstilling av interleukin-1-inhibitorer, og rekombinant vertcelle s

Country Status (9)

Country Link
JP (2) JP3192651B2 (no)
KR (1) KR970002917B1 (no)
BR (1) BR8907457A (no)
DK (1) DK172763B1 (no)
FI (2) FI109206B (no)
HU (3) HU215434B (no)
NO (2) NO316122B1 (no)
OA (1) OA09631A (no)
WO (1) WO1989011540A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
AU655766B2 (en) * 1990-05-01 1995-01-12 Chiron Corporation Interleukin-1 antagonist and uses thereof
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
US5824549A (en) * 1990-10-09 1998-10-20 Chiron Corporation Transformed human T cell
ZA921120B (en) 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
CN103232539B (zh) 2001-06-26 2015-06-03 安姆根弗里蒙特公司 抗opgl抗体
JP2005507915A (ja) * 2001-10-26 2005-03-24 ノバルティス アクチエンゲゼルシャフト 変形性関節症の処置方法およびその組成物
JP4761710B2 (ja) 2002-04-05 2011-08-31 アムジェン インコーポレイテッド 選択的ｏｐｇｌ経路インヒビターとしてのヒト抗ｏｐｇｌ中和抗体
AU2005267722B2 (en) 2004-08-04 2009-10-08 Amgen Inc. Antibodies to Dkk-1
EP3330292A1 (en) 2007-08-21 2018-06-06 Amgen, Inc Human c-fms antigen binding proteins
US8242074B2 (en) * 2008-09-12 2012-08-14 Xbiotech, Inc. Modulation of the amount or function of pathogenic CD14+CD16+ monocytes
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
ES2600616T3 (es) 2011-03-14 2017-02-10 Phlogo Aps Antagonistas del receptor de la interleucina-1
CN103492416A (zh) 2011-04-15 2014-01-01 默克专利股份公司 用于癌症中使用的抗il-1r1抑制剂
TW201605896A (zh) 2013-08-30 2016-02-16 安美基股份有限公司 Gitr抗原結合蛋白
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
SG11201807596YA (en) 2016-03-08 2018-10-30 Janssen Biotech Inc Gitr antibodies, methods, and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2220662A (en) * 1987-08-26 1990-01-17 Biogen Inc Biological materials,processes for producing biological materials and for using such materials in therapy

Also Published As

Publication number Publication date
FI20020545A7 (fi) 2002-03-21
HU893412D0 (en) 1991-05-28
FI905812A0 (fi) 1990-11-26
FI109206B (fi) 2002-06-14
HU9803037D0 (en) 1999-11-29
HU215434B (hu) 1999-04-28
OA09631A (en) 1993-04-30
JPH03505279A (ja) 1991-11-21
KR970002917B1 (ko) 1997-03-12
WO1989011540A1 (en) 1989-11-30
FI20020545L (fi) 2002-03-21
DK8591A (da) 1991-01-18
DK8591D0 (da) 1991-01-18
JP2001029093A (ja) 2001-02-06
NO20014783L (no) 1991-01-28
AU3746989A (en) 1989-12-12
BR8907457A (pt) 1991-04-02
DK172763B1 (da) 1999-07-05
AU633831B2 (en) 1993-02-11
NO905090L (no) 1991-01-28
NO316917B1 (no) 2004-06-21
NO316122B1 (no) 2003-12-15
NO905090D0 (no) 1990-11-23
JP3192651B2 (ja) 2001-07-30
HU222810B1 (hu) 2003-11-28

Similar Documents

Publication Publication Date Title
NO20014783L (no) DNA-sekvens som koder for interleukin-1-inhibitorer og fremgangsmåte til fremstilling av forbindelsene
NO922675L (no) Pakningselement, og fremgangsmaate til fremstilling derav
DK313086A (da) Phenoxyalkylisoxazol- eller -furanforbindelse og fremgangsmaade til fremstilling deraf
DK51286A (da) Desoxyadenosinphosphatforbindelser og fremgangsmaade til fremstilling afdisse
DK376986D0 (da) Di-tert-butylphenol-forbindelser og fremgangsmaade til fremstilling heraf
DK301886D0 (da) Furanon-derivater og fremgangsmaade til fremstilling heraf
DK50889D0 (da) Cyclomaltodextringlucantransferase og fremgangsmaade til fremstilling heraf
DK435588D0 (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
DK355387D0 (da) Overtraekspraeparat og fremgangsmaade til anvendelse deraf
NO174334C (no) Fremgangsmåte og innretning til fremstilling av fiberplater
DK187989D0 (da) Substituerede propanaminer, fremgangsmaade til fremstilling heraf og laegemidler indeholdende saadanne forbindelser
DK251087D0 (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
NO860092L (no) Korrosjons-inhibitor og fremgangsmaate til fremstilling derav.
DK39689D0 (da) Fremgangsmaade til fremstilling af n-phosphonmethyliminodieddikesyre og n-phosphonmethyliminodieddikesyrechlorid
DK69387D0 (da) Cyanoderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne
DK0390762T3 (da) Hidtil ukendte bronchospasmolytiske forbindelser og fremgangsmåde til fremstilling heraf
DK190589A (da) Quinolin-3-carboxylsyreforbindelser, fremgangsmaade til fremstilling heraf og farmaceutisk middel omfattende samme
IS1410B6 (is) Aðferð og búnaður til fiskeldis
DK515686A (da) Dopamin-beta-hydroxylase-inhibitorer og fremgangsmaade til fremstillingderaf
DK428986D0 (da) Fremgangsmaade og indretning til undervandsfastgoerelse
DK190290D0 (da) Fremgangsmaade til methanomdannelse
DK123886A (da) 2-amino-4-trichlormethyl-pyridin, fremgangsmaade til fremstilling deraf og anvendelse deraf som nitrifikationshaemmende middel
DK665188D0 (da) Undersoegelsesmetode for antigenbinding og forbindelser til anvendelse herved
DK272885A (da) Fremgangsmaade til fremstilling af zeolitkatalysatorer og alkyleringsproces
DK50686A (da) Difficolforbindelse og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
MK1K Patent expired